Case number 1:19-cv-00474
UCB, Inc. et al v. Actavis Laboratories UT, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 16, 2023 | 206 | MANDATE of USCA as to 200 Notice of Appeal (Federal Circuit) filed by LTS Lohmann Therapie-Systeme AG, UCB, Inc., UCB Pharma GmbH. USCA Decision: AFFIRMED. (Attachments: # 1 Order Recalling Previous Mandate, # 2 Errata, # 3 Opinion, # 4 Judgment)(smg) (Entered: 06/16/2023) (Main Document) (2) |
| Jun 16, 2023 | 206 | MANDATE of USCA as to 200 Notice of Appeal (Federal Circuit) filed by LTS Lohmann Therapie-Systeme AG, UCB, Inc., UCB Pharma GmbH. USCA Decision: AFFIRMED. (Attachments: # 1 Order Recalling Previous Mandate, # 2 Errata, # 3 Opinion, # 4 Judgment)(smg) (Entered: 06/16/2023) (Order Recalling Previous Mandate) (2) |
| Jun 16, 2023 | 206 | MANDATE of USCA as to 200 Notice of Appeal (Federal Circuit) filed by LTS Lohmann Therapie-Systeme AG, UCB, Inc., UCB Pharma GmbH. USCA Decision: AFFIRMED. (Attachments: # 1 Order Recalling Previous Mandate, # 2 Errata, # 3 Opinion, # 4 Judgment)(smg) (Entered: 06/16/2023) (Errata) (2) |
| Jun 16, 2023 | 206 | MANDATE of USCA as to 200 Notice of Appeal (Federal Circuit) filed by LTS Lohmann Therapie-Systeme AG, UCB, Inc., UCB Pharma GmbH. USCA Decision: AFFIRMED. (Attachments: # 1 Order Recalling Previous Mandate, # 2 Errata, # 3 Opinion, # 4 Judgment)(smg) (Entered: 06/16/2023) (Opinion) (28) |
| Jun 16, 2023 | 206 | MANDATE of USCA as to 200 Notice of Appeal (Federal Circuit) filed by LTS Lohmann Therapie-Systeme AG, UCB, Inc., UCB Pharma GmbH. USCA Decision: AFFIRMED. (Attachments: # 1 Order Recalling Previous Mandate, # 2 Errata, # 3 Opinion, # 4 Judgment)(smg) (Entered: 06/16/2023) (Judgment) (2) |
| May 26, 2023 | 205 | MANDATE of USCA as to 200 Notice of Appeal (Federal Circuit) filed by LTS Lohmann Therapie-Systeme AG, UCB, Inc., UCB Pharma GmbH. USCA Decision: AFFIRMED. (Attachments: # 1 Opinion, # 2 Judgment)(smg) MANDATE RECALLED on 06/16/2023, SEE D.I. 206 (smg). (Entered: 05/26/2023) (Main Document) (2) |
| May 26, 2023 | 205 | MANDATE of USCA as to 200 Notice of Appeal (Federal Circuit) filed by LTS Lohmann Therapie-Systeme AG, UCB, Inc., UCB Pharma GmbH. USCA Decision: AFFIRMED. (Attachments: # 1 Opinion, # 2 Judgment)(smg) MANDATE RECALLED on 06/16/2023, SEE D.I. 206 (smg). (Entered: 05/26/2023) (Opinion) (28) |
| May 26, 2023 | 205 | MANDATE of USCA as to 200 Notice of Appeal (Federal Circuit) filed by LTS Lohmann Therapie-Systeme AG, UCB, Inc., UCB Pharma GmbH. USCA Decision: AFFIRMED. (Attachments: # 1 Opinion, # 2 Judgment)(smg) MANDATE RECALLED on 06/16/2023, SEE D.I. 206 (smg). (Entered: 05/26/2023) (Judgment) (2) |
| Apr 1, 2022 | N/A | Case No Longer Referred to Mediation (0) Docket Text: CASE NO LONGER REFERRED to Magistrate Judge Fallon for the purpose of exploring ADR. Please see the Court's Standing Order No. 2022-2 dated March 14, 2022. (lih) |
| Sep 7, 2021 | 204 | Notice Requesting Removal of Co-Counsel (2) Docket Text: NOTICE requesting Clerk to remove Alaina Whitt as co-counsel. Reason for request: no longer with firm. (Raucci, Anthony) |
| May 7, 2021 | 203 | Notice (Other) (2) Docket Text: NOTICE of Withdrawal of Counsel by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc. (Blumenfeld, Jack) |
| May 6, 2021 | 201 | USCA Notice of Docketing ROA (4) Docket Text: NOTICE of Docketing Record on Appeal from USCA for the Federal Circuit re [200] Notice of Appeal (Federal Circuit) filed by LTS Lohmann Therapie-Systeme AG, UCB, Inc., and UCB Pharma GmbH. USCA Case Number 21-1924. (nmg) |
| May 6, 2021 | 202 | Appeal Transcript Request (1) Docket Text: TRANSCRIPT REQUEST by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc. TRANSCRIPT NOT NEEDED (Raucci, Anthony) |
| May 3, 2021 | N/A | APPEAL - Credit Card Payment (0) Docket Text: APPEAL - Credit Card Payment of $505.00 received re [200] Notice of Appeal (Federal Circuit) filed by LTS Lohmann Therapie-Systeme AG, UCB, Inc., UCB Pharma GmbH. ( Filing fee $505, receipt number ADEDC-3606520.) (Raucci, Anthony) |
| May 3, 2021 | N/A | Description not available (0) Docket Text: Notification regarding [200] Notice of Appeal (Federal Circuit) sent to Reporter Gaffigan. (nmg) |
| May 3, 2021 | N/A | Description not available (0) Docket Text: Notification regarding [200] Notice of Appeal (Federal Circuit) sent to Reporter Gunning. (nmg) |
| May 3, 2021 | N/A | Notice of Appeal and Docket Sheet to USCA (0) Docket Text: Notice of Appeal and Docket Sheet to US Court of Appeals for the Federal Circuit re [200] Notice of Appeal (Federal Circuit). (nmg) |
| May 3, 2021 | 200 | Notice of Appeal (Federal Circuit) (3) Docket Text: NOTICE OF APPEAL to the Federal Circuit of [196] Judgment, . Appeal filed by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc.. (Raucci, Anthony) |
| May 3, 2021 | 200 | Notice of Appeal* (1) |
| Apr 20, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys George F. Pappas, Richard L. Rainey, Alaina Whitt, Alexa R. Hansen for LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Apr 16, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [198] MOTION for Pro Hac Vice Appearance of Attorney George F. Pappas, Richard L. Rainey, Alaina Whitt and Alexa Hansen filed by LTS Lohmann Therapie-Systeme AG, UCB, Inc., UCB Pharma GmbH. Signed by Judge Kent A. Jordan on 4/16/2021. (cna, ) |
| Apr 12, 2021 | 198 | Motion for Leave to Appear Pro Hac Vice (7) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney George F. Pappas, Richard L. Rainey, Alaina Whitt and Alexa Hansen - filed by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc.. (Raucci, Anthony) |
| Apr 12, 2021 | 199 | Order (1) Docket Text: In accordance with the Court's March 26, 2021 Order (D.I. [192]), the Clerk's Office is hereby directed to unseal the Findings of Fact and Conclusions Law March 26, 2021 (D.I. [191]).(amf) |
| Apr 7, 2021 | 195 | Main Document (1) Docket Text: Letter to The Honorable Kent A. Jordan from James L. Higgins regarding Joint Proposed Form of Judgment - re [191] Findings of Fact & Conclusions of Law. (Attachments: # (1) Exhibit A)(Higgins, James) |
| Apr 7, 2021 | 195 | Exhibit A (2) |
| Apr 7, 2021 | 196 | Judgment (1) Docket Text: JUDGMENT in favor of Actavis Laboratories UT, Inc. against LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc. and all claims for relief requested in Plaintiffs' Complaint for Patent Infringement D.I. [1] are denied with prejudice; Judgment is entered in favor of Defendant and against Plaintiffs on Defendant's counterclaim that claims 1, 2, 3, 7, 10, 11, and 12 of U.S. Patent No. 10,130,589 (the '589 Patent) are invalid.. Signed by Judge Kent A. Jordan on 4/7/21. (mal) |
| Apr 7, 2021 | N/A | Order on Motion for Extension of Time (0) Docket Text: ORDER denying D.I. [194] Motion for Extension of Time as moot. Signed by Judge Kent A. Jordan on 4/7/21. (mal) |
| Apr 5, 2021 | 194 | Motion for Extension of Time (4) Docket Text: MOTION for Extension of Time to Submit Proposed Form of Judgment (Unopposed) - filed by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc.. (Fahnestock, Derek) |
| Mar 26, 2021 | 191 | Findings of Fact & Conclusions of Law (65) Docket Text: FINDINGS OF FACT AND CONCLUSIONS OF LAW. Signed by Judge Kent A. Jordan on 3/26/2021.This order has been emailed to local counsel. (cna, ) (*Document unsealed per DI [199] Court Order) |
| Mar 26, 2021 | 192 | Order (1) Docket Text: ORDER, IT IS HEREBY ORDERED that counsel shall provide the Court with proposed redactions on or before the close of business on April 7, 2021. After that time the Court will unseal the [191] Findings of Fact and Conclusions of Law, setting forth the rulings, with any redactions deemed appropriate by the Court. Signed by Judge Kent A. Jordan on 3/26/2021. (cna, ) |
| Mar 26, 2021 | 193 | Order (1) Docket Text: ORDER, IT IS HEREBY ORDERED that the parties shall confer and, within ten days, submit a form of judgment order giving effect to the conclusions set forth herein. Signed by Judge Kent A. Jordan on 3/26/2021. (cna, ) |
| Mar 24, 2021 | N/A | Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Kent A. Jordan: Telephone Conference held on 3/24/2021. (Court Reporter Val Gunning.) (nmg) |
| Mar 11, 2021 | 190 | Notice (Other) (3) Docket Text: NOTICE of Withdrawal of Counsel (Jennifer A. Ward) by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc. (Ward, Jennifer) |
| Jan 20, 2021 | 189 | Notice (Other) (1) Docket Text: NOTICE of Withdrawal of Counsel, Steven W. Lee by Actavis Laboratories UT, Inc. (Higgins, James) |
| Jan 4, 2021 | 186 | Redacted Document (5) Docket Text: REDACTED VERSION of [185] MOTION to Redact [178] Transcript,, [Unopposed] by Actavis Laboratories UT, Inc.. (Lee, Steven) |
| Jan 4, 2021 | 187 | Order on Motion to Redact Transcript (1) Docket Text: ORDER, granting D.I.[185] Motion to Redact D.I.[178] Transcript. Signed by Judge Kent A. Jordan on 1/4/2021. (myr) |
| Dec 21, 2020 | 184 | Statement (3) Docket Text: STATEMENT re [176] Statement -- Reply in Support of Request for Judicial Notice -- by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc.. (Blumenfeld, Jack) |
| Dec 18, 2020 | 182 | Redacted Document (30) Docket Text: REDACTED VERSION of [177] POST Trial Brief [Actavis's Responsive Post-Trial Brief] by Actavis Laboratories UT, Inc.. (Lee, Steven) |
| Dec 18, 2020 | 183 | Letter (1) Docket Text: Letter to The Honorable Kent A. Jordan from James L. Higgins, Esq. regarding Hyperlinked Versions of Actavis's Post-Trial Submissions - re [161] POST Trial Brief, [160] Proposed Findings of Fact, [177] POST Trial Brief. (Higgins, James) |
| Dec 17, 2020 | 180 | Letter (1) Docket Text: Letter to The Honorable Kent A. Jordan from Jennifer A. Ward regarding Plaintiffs' hyperlinked post-trial briefing. (Ward, Jennifer) |
| Dec 17, 2020 | 181 | Notice of Intent to Request Transcript Redaction (2) Docket Text: NOTICE of Intent to Request Redaction by James L. Higgins re [178] Transcript,, (Higgins, James) |
| Dec 14, 2020 | 179 | Statement (5) Docket Text: STATEMENT re [176] Statement [Actavis's Response to Plaintiffs' Request for Judicial Notice] by Actavis Laboratories UT, Inc.. (Higgins, James) |
| Dec 11, 2020 | 175 | POST Trial Brief (30) Docket Text: POST TRIAL BRIEF (Plaintiffs' Responsive Post-Trial Brief) by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc.. (Ward, Jennifer) |
| Dec 11, 2020 | 176 | Main Document (7) Docket Text: STATEMENT [Plaintiffs' Request for Judicial Notice] by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc.. (Attachments: # (1) Exhibits A-C)(Ward, Jennifer) |
| Dec 11, 2020 | 176 | Exhibits A-C (27) |
| Nov 24, 2020 | 171 | Redacted Document (30) Docket Text: REDACTED VERSION of [160] Proposed Findings of Fact and Conclusions of Law by Actavis Laboratories UT, Inc.. (Higgins, James) |
| Nov 24, 2020 | 172 | Redacted Document (20) Docket Text: REDACTED VERSION of [161] POST Trial Brief by Actavis Laboratories UT, Inc.. (Higgins, James) |
| Nov 24, 2020 | 173 | Main Document (30) Docket Text: REDACTED VERSION of [162] POST Trial Brief by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc.. (Attachments: # (1) Appendix 1, # (2) Appendix 2)(Raucci, Anthony) |
| Nov 24, 2020 | 173 | Appendix 1 (2) |
| Nov 24, 2020 | 173 | Appendix 2 (2) |
| Nov 24, 2020 | 174 | Redacted Document (30) Docket Text: REDACTED VERSION of [163] Proposed Findings of Fact by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc.. (Raucci, Anthony) |
| Nov 19, 2020 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: Replaced D.I 163 original document per Counsel's request. (mal) |
| Nov 19, 2020 | 166 | Redacted Document (5) Docket Text: REDACTED VERSION of [164] MOTION to Redact [155] Transcript, [154] Transcript,, [157] Transcript [Unopposed] by Actavis Laboratories UT, Inc.. (Higgins, James) |
| Nov 19, 2020 | 167 | Order on Motion to Redact Transcript (1) Docket Text: ORDER granting [164] Motion to Redact [154] Transcript, [155] Transcript, [156] Transcript. Signed by Judge Kent A. Jordan on 11/19/2020. (kmd) |
| Nov 19, 2020 | 168 | Redacted Transcript (255) Docket Text: REDACTED VERSION of [154] Official Transcript of Bench Trial - Volume A held on October 7, 2020 before Circuit Judge Kent A. Jordan. Court Reporter Brian Gaffigan, email: gaffigan@verizon.net. Transcript may be viewed at the court public terminal or ordered/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. (kmd) |
| Nov 19, 2020 | 169 | Redacted Transcript (4) Docket Text: REDACTED VERSION of [155] Transcript of Bench Trial - Volume A held on October 7, 2020 before Circuit Judge Kent A. Jordan. (kmd) |
| Nov 19, 2020 | 170 | Redacted Transcript (8) Docket Text: REDACTED VERSION of [157] Transcript of Bench Trial - Volume B held on October 8, 2020 before Circuit Judge Kent A. Jordan. (kmd) |
| Nov 18, 2020 | 165 | Proposed Order (1) Docket Text: PROPOSED ORDER Granting Defendant's Unopposed Motion to Redact re [164] MOTION to Redact [155] Transcript, [154] Transcript,, [157] Transcript [Unopposed] by Actavis Laboratories UT, Inc.. (Higgins, James) |
| Nov 4, 2020 | 156 | Transcript (272) Docket Text: Official Transcript of Bench Trial - Volume B held on October 8, 2020 before Circuit Judge Kent A. Jordan. Court Reporter Brian Gaffigan, email: gaffigan@verizon.net. Transcript may be viewed at the court public terminal or ordered/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 11/25/2020. Redacted Transcript Deadline set for 12/7/2020. Release of Transcript Restriction set for 2/2/2021. (bpg) |
| Nov 4, 2020 | 158 | Transcript (292) Docket Text: Official Transcript of Bench Trial - Volume C held on October 9, 2020 before Circuit Judge Kent A. Jordan. Court Reporter Brian Gaffigan, email: gaffigan@verizon.net. Transcript may be viewed at the court public terminal or ordered/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 11/25/2020. Redacted Transcript Deadline set for 12/7/2020. Release of Transcript Restriction set for 2/2/2021. (bpg) |
| Nov 4, 2020 | 159 | Notice of Intent to Request Transcript Redaction (2) Docket Text: NOTICE of Intent to Request Redaction by James L. Higgins re [154] Transcript,, (Higgins, James) |
| Oct 19, 2020 | 153 | Disclosure Statement (3) Docket Text: Amended Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent UCB Pharma GmbH for UCB Pharma GmbH; Corporate Parent UCB S.A. through UCB Holding Inc., Corporate Parent UCB S.A. & UCB Finance N.V. for UCB, Inc.; Other Affiliate LTS Lohmann Therapie Systems AG for LTS Lohmann Therapie-Systeme AG filed by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc.. (Raucci, Anthony) |
| Oct 16, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [151] Stipulation filed by LTS Lohmann Therapie-Systeme AG, UCB, Inc., UCB Pharma GmbH. Signed by Judge Kent A. Jordan on 10/16/2020. (kmd) |
| Oct 14, 2020 | 151 | Stipulation (2) Docket Text: STIPULATION and [Proposed] Order Regarding Post-Trial Briefing by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc.. (Fahnestock, Derek) |
| Oct 13, 2020 | 150 | Redacted Document (2) Docket Text: REDACTED VERSION of [148] Exhibit to a Document by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc.. (Ward, Jennifer) |
| Oct 9, 2020 | N/A | Bench Trial - Completed (0) Docket Text: Minute Entry for proceedings held before Judge Kent A. Jordan - Bench Trial Day 3 (via Zoom) completed on 10/9/2020. (Court Reporters Brian Gaffigan and Valerie Gunning.) (amf) |
| Oct 8, 2020 | N/A | Bench Trial - Held (0) Docket Text: Minute Entry for proceedings held before Judge Kent A. Jordan - Bench Trial Day 2 (via Zoom) held on 10/8/2020. (Court Reporters Brian Gaffigan and Valerie Gunning.) (amf) |
| Oct 7, 2020 | N/A | Bench Trial - Begun (0) Docket Text: Minute Entry for proceedings held before Judge Kent A. Jordan - Bench Trial Day 1 (via Zoom) held on 10/7/2020. (Court Reporters Brian Gaffigan and Valerie Gunning.) (amf) |
| Oct 7, 2020 | 149 | Letter (1) Docket Text: Letter to The Honorable Kent A. Jordan from Jennifer A. Ward regarding linked index containing trial exhibits. (Ward, Jennifer) |
| Oct 6, 2020 | N/A | Remark (0) Docket Text: Remark - The public dial-in information for the Bench Trial beginning 10/7/2020 is as follows: Audio only dial-in. Select a number for the location nearest to you.+1 646 876 9923 US (New York); +1 301 715 8592 US (Germantown); +1 312 626 6799 US (Chicago); +1 346 248 7799 US (Houston); +1 669 900 6833 US (San Jose); +1 253 215 8782 US (Tacoma). Meeting ID: 930 6212 4547 Passcode: 648427. (amf) |
| Oct 1, 2020 | 147 | SO ORDERED (1) Docket Text: SO ORDERED - re [146] STIPULATION TO EXTEND TIME for the parties to narrow their respective exhibit lists to October 2, 2020. Signed by Judge Kent A. Jordan on 10/1/2020. (amf) |
| Sep 30, 2020 | 146 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME for the parties to narrow their respective exhibit lists to October 2, 2020 - filed by Actavis Laboratories UT, Inc.. (Higgins, James) |
| Sep 25, 2020 | 145 | Order (1) Docket Text: ORDER: In accordance with the Court's Order [137], the Clerk'sOffice is hereby directed to unseal the Memorandum Opinion and Order ofSeptember 16, 2020. Document unsealed: [135] Memorandum Opinion, [136] Order.. Signed by Judge Kent A. Jordan on 9/25/2020. (kmd) |
| Sep 24, 2020 | 144 | Letter (1) Docket Text: Letter to The Honorable Kent A. Jordan from Jennifer A. Ward regarding No Redactions Necessary to the Court's September 16, 2020 Memorandum Opinion and Order - re [135] Memorandum Opinion, [136] Order. (Ward, Jennifer) |
| Sep 23, 2020 | 141 | Redacted Document (13) Docket Text: REDACTED VERSION of [133] Reply Brief in Support of its Request that Plaintiffs be Judicially Estopped by Actavis Laboratories UT, Inc.. (Lee, Steven) |
| Sep 23, 2020 | 142 | Redacted Document (30) Docket Text: REDACTED VERSION of [134] Declaration of James L. Higgins by Actavis Laboratories UT, Inc.. (Lee, Steven) |
| Sep 23, 2020 | 143 | Main Document (25) Docket Text: REDACTED VERSION of [131] Statement, by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc.. (Attachments: # (1) Exhibit A-I)(Raucci, Anthony) |
| Sep 23, 2020 | 143 | Exhibit A-I (35) |
| Sep 21, 2020 | 139 | Main Document (19) Docket Text: REDACTED VERSION of [132] Proposed Pretrial Order by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc.. (Attachments: # (1) Exhibits 1-12)(Ward, Jennifer) |
| Sep 21, 2020 | 139 | Exhibits 1-12 (163) |
| Sep 21, 2020 | 140 | Redacted Document (30) Docket Text: REDACTED VERSION of [130] Notice (Other) [Amended Notice of Disclosure of Prior Art Pursuant to 35 U.S.C. § 282] by Actavis Laboratories UT, Inc.. (Lee, Steven) |
| Sep 18, 2020 | N/A | Pretrial Conference - Final (0) Docket Text: Minute Entry for proceedings held before Judge Kent A. Jordan - Final Pretrial Teleconference held on 9/18/2020. (Court Reporter Jennifer Guy.) (amf) |
| Sep 18, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re [138] MOTION for Pro Hac Vice Appearance of Attorney Richard J. Shea of Fenwick & West LLP. Ordered by Judge Kent A. Jordan on 9/18/2020. (amf) |
| Sep 18, 2020 | 138 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Richard J. Shea of Fenwick & West LLP - filed by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc.. (Ward, Jennifer) |
| Sep 17, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Alina Afinogenova for Actavis Laboratories UT, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Sep 17, 2020 | 137 | Order (1) Docket Text: ORDER - Counsel shall provide the Court with proposed redactions to the Sealed Memorandum Opinion (D.I. [135]) on or before the close of business on September 24, 2020. After that time the Court will unseal the Memorandum Opinion, setting forth the rulings, with any redactions deemed appropriate by the Court. Signed by Judge Kent A. Jordan on 9/17/2020. (amf) |
| Sep 16, 2020 | 135 | Memorandum Opinion (10) Docket Text: MEMORANDUM OPINION. Signed by Judge Kent A. Jordan on 9/16/2020.This order has been emailed to local counsel. (myr) Modified on 9/25/2020 (kmd). |
| Sep 16, 2020 | 136 | Order (1) Docket Text: ORDER: Plaintiffs' Motion to Exclude Expert Opinion of Rahul Guha under Rule 702 and Daubert (D.I. 103) is Denied. re D.I.[103] MOTION. Signed by Judge Kent A. Jordan on 9/16/2020.This order has been emailed to local counsel. (myr) Modified on 9/25/2020 (kmd). |
| Sep 11, 2020 | 126 | Redacted Document (26) Docket Text: REDACTED VERSION of [121] Opening Brief in Support of its Request that Plaintiffs be Judicially Estopped by Actavis Laboratories UT, Inc.. (Lee, Steven) |
| Sep 11, 2020 | 127 | Main Document (93) Docket Text: REDACTED VERSION of [122] Declaration, of James L. Higgins by Actavis Laboratories UT, Inc.. (Attachments: # (1) Part 2, # (2) Part 3)(Lee, Steven) |
| Sep 11, 2020 | 127 | Part 2 (80) |
| Sep 11, 2020 | 127 | Part 3 (41) |
| Sep 11, 2020 | 128 | Redacted Document (30) Docket Text: REDACTED VERSION of [120] Notice (Other) of Disclosure of Prior Art Pursuant to 35 U.S.C. § 282 by Actavis Laboratories UT, Inc.. (Lee, Steven) |
| Sep 11, 2020 | 129 | Scheduling Order (2) Docket Text: AMENDED SCHEDULING ORDER: A Final Pretrial Conference is set for 2/18/2020 at 02:00 PM before Judge Kent A. Jordan. A 3-day Bench Trial is set to begin on 10/7/2020 at 09:00 AM before Judge Kent A. Jordan. Signed by Judge Kent A. Jordan on 9/11/2020. (SEE ORDER FOR FURTHER DETAILS) (cna, ) |
| Sep 8, 2020 | 124 | Redacted Document (15) Docket Text: REDACTED VERSION of [117] Reply Brief in Support of its Motion to Exclude Expert Testimony and Opinion of D.R. Rahul Guha Under Rule 702 and Daubert by Actavis Laboratories UT, Inc.. (Lee, Steven) |
| Sep 8, 2020 | 125 | Redacted Document (23) Docket Text: REDACTED VERSION of [118] Declaration of James L. Higgins in Support of Defendant's Motion to Exclude the Expert Opinion of Rahul Guha Under Rule 702 and Daubert by Actavis Laboratories UT, Inc.. (Lee, Steven) |
| Sep 4, 2020 | 123 | Status Report (2) Docket Text: Joint STATUS REPORT by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc.. (Blumenfeld, Jack) |
| Sep 3, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re [116] Proposed Order and Stipulation regarding Briefing Schedule. Ordered by Judge Kent A. Jordan on 9/3/2020. (amf) |
| Sep 2, 2020 | 119 | Transcript (28) Docket Text: Official Transcript of Telephone Conference held on August 28, 2020 before Circuit Judge Kent A. Jordan and Chief Judge Leonard P. Stark. Court Reporter Brian Gaffigan, e-mail: gaffigan@verizon.net. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 9/23/2020. Redacted Transcript Deadline set for 10/5/2020. Release of Transcript Restriction set for 12/1/2020. (bpg) |
| Sep 1, 2020 | 116 | Proposed Order (2) Docket Text: PROPOSED ORDER and Stipulation regarding Briefing Schedule by Actavis Laboratories UT, Inc.. (Higgins, James) |
| Aug 31, 2020 | 114 | Redacted Document (3) Docket Text: REDACTED VERSION of [109] Letter regarding Response to Plaintiffs' August 20, 2020 Letter by Actavis Laboratories UT, Inc.. (Sharp, Melanie) |
| Aug 31, 2020 | 115 | Main Document (23) Docket Text: REDACTED VERSION of [110] Answering Brief in Opposition, by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc.. (Attachments: # (1) Exhibits A-C)(Ward, Jennifer) |
| Aug 31, 2020 | 115 | Exhibits A-C (3) |
| Aug 28, 2020 | N/A | Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Leonard P. Stark and Judge Kent A. Jordan - Telephone Conference held on 8/28/2020. (Court Reporter B. Gaffigan.) (ntl) |
| Aug 28, 2020 | 113 | Order (1) Docket Text: ORDER: DESIGNATION OF CIRCUIT JUDGE TO HOLD A DISTRICT COURT WITHIN THE CIRCUIT, designating and assigning the Honorable Kent A. Jordan of the United States Court of Appeals for the Third Circuit. Signed by Judge D. Brooks Smith, Chief Judge of the United States Court of Appeals for the Third Circuit on 8/28/20. (rjb) |
| Aug 27, 2020 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Reassigned to Judge Kent A. Jordan. Please include the initials of the Judge (KAJ) after the case number on all documents filed. (gvw) |
| Aug 27, 2020 | 112 | Status Report (2) Docket Text: Joint STATUS REPORT - by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc.. (Blumenfeld, Jack) |
| Aug 25, 2020 | N/A | Order Setting Teleconference (0) Docket Text: ORAL ORDER: Having reviewed the parties' recent letters (D.I. 108, 109), IT IS HEREBY ORDERED that: (i) the parties shall file a joint status report no later than Thursday, August 27; and (ii) the Court will hold a status teleconference on Friday, August 28 at 9:15, with Plaintiffs providing the parties and the Court the necessary call-in information. The Court's present inclination is to convert the upcoming pretrial conference and trial to virtual proceedings to be conducted with video-conferencing technology but welcomes the parties' preferences and suggestions, which should be included in the status report. ORDERED by Judge Leonard P. Stark on 8/25/20. (ntl) |
| Aug 20, 2020 | 108 | Letter (1) Docket Text: Letter to The Honorable Leonard P. Stark from Jack B. Blumenfeld regarding request for a teleconference to discuss trial planning. (Blumenfeld, Jack) |
| Aug 19, 2020 | 106 | Redacted Document (21) Docket Text: REDACTED VERSION of [104] Opening Brief in Support, Defendant's Opening Brief in support of its Motion to Exclude Expert Opinion of Rahul Guha Under Rule 702 and Daubert by Actavis Laboratories UT, Inc.. (Higgins, James) |
| Aug 19, 2020 | 107 | Redacted Document (30) Docket Text: REDACTED VERSION of [105] Declaration, of James L. Higgins in Support of Defendant's Motion to Exclude the Expert Opinion of Rahul Guha by Actavis Laboratories UT, Inc.. (Higgins, James) |
| Aug 12, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [102] Joint STIPULATION TO EXTEND TIME PreTrial Order exchanges (various events) to various dates filed by LTS Lohmann Therapie-Systeme AG, UCB, Inc., UCB Pharma GmbH. Signed by Judge Leonard P. Stark on 8/12/20. (ntl) |
| Aug 12, 2020 | 103 | Motion for Miscellaneous Relief (4) Docket Text: MOTION to Exclude Expert Testimony and Opinion of D.R. Rahul Guha - filed by Actavis Laboratories UT, Inc.. (Higgins, James) |
| Aug 7, 2020 | 102 | Stipulation to EXTEND Time (2) Docket Text: Joint STIPULATION TO EXTEND TIME PreTrial Order exchanges (various events) to various dates - filed by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc.. (Raucci, Anthony) |
| Jul 14, 2020 | 99 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Ivan T. Hofmann on July 17, 2020 filed by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc..(Raucci, Anthony) |
| Jul 14, 2020 | 100 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Dr. Mark Prausnitz on July 29, 2020 filed by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc..(Raucci, Anthony) |
| Jul 14, 2020 | 101 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Robin D. Rogers, Ph.D. on July 22, 2020 filed by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc..(Raucci, Anthony) |
| Jul 10, 2020 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: Corrected document added to D.I. 93 per request of counsel. (ntl) |
| Jul 10, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [93] STIPULATION and [Proposed] Order Regarding Deadline for Expert Depositions and Pretrial Order filed by LTS Lohmann Therapie-Systeme AG, UCB, Inc., UCB Pharma GmbH. Signed by Judge Leonard P. Stark on 7/10/20. (ntl) |
| Jul 9, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [98] MOTION for Pro Hac Vice Appearance of Attorney Alina Afinogenova filed by Actavis Laboratories UT, Inc. Signed by Judge Leonard P. Stark on 7/9/20. (ntl) |
| Jul 8, 2020 | 98 | Main Document (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Alina Afinogenova - filed by Actavis Laboratories UT, Inc.. (Attachments: # (1) Certification by Counsel)(Higgins, James) |
| Jul 8, 2020 | 98 | Certification by Counsel (1) |
| Jul 6, 2020 | 93 | Stipulation (2) Docket Text: STIPULATION and [Proposed] Order Regarding Deadline for Expert Depositions and Pretrial Order by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc.. (Fahnestock, Derek) (Main Document 93 replaced on 7/10/2020) (ntl). |
| Jul 6, 2020 | 94 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Anthony Nicholas on July 10, 2020 filed by Actavis Laboratories UT, Inc..(Higgins, James) |
| Jul 6, 2020 | 95 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Rahul Guha on July 23, 2020 filed by Actavis Laboratories UT, Inc..(Higgins, James) |
| Jul 6, 2020 | 96 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Allan S. Myerson on July 24, 2020 filed by Actavis Laboratories UT, Inc..(Higgins, James) |
| Jul 6, 2020 | 97 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Richard Guy on July 31, 2020 filed by Actavis Laboratories UT, Inc..(Higgins, James) |
| Jun 12, 2020 | 92 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Reply Expert Report of Robin D. Rogers, Ph.D., (2) Reply Expert Report of Ivan T. Hofmann, and (3) Reply Expert Report of Mark Prausnitz, Ph.D. Concerning the Invalidity of U.S. Patent No. 10,130,589 filed by Actavis Laboratories UT, Inc..(Lee, Steven) |
| May 15, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [90] STIPULATION TO EXTEND TIME regarding Expert Discovery Deadlines (see Stipulation for details) filed by Actavis Laboratories UT, Inc. Signed by Judge Leonard P. Stark on 5/13/20. (ntl) |
| May 14, 2020 | 91 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Rebuttal Expert Report of Allan S. Myerson, Ph.D.; (2) Expert Report of Anthony Nicholas, M.D., Ph.D.; (3) Expert Report of Rahul Guha, Ph.D.; and (4) Responsive Expert Report of Richard Guy, Ph.D. filed by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc..(Raucci, Anthony) |
| May 8, 2020 | 90 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME regarding Expert Discovery to (see Stipulation for details) - filed by Actavis Laboratories UT, Inc.. (Higgins, James) |
| Apr 13, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [89] Joint STIPULATION TO EXTEND TIME expert discovery to various dates filed by LTS Lohmann Therapie-Systeme AG, UCB, Inc., UCB Pharma GmbH. Signed by Judge Leonard P. Stark on 4/7/20. (ntl) |
| Apr 3, 2020 | 89 | Stipulation to EXTEND Time (2) Docket Text: Joint STIPULATION TO EXTEND TIME expert discovery to various dates - filed by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc.. (Raucci, Anthony) |
| Apr 1, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [87] STIPULATION TO EXTEND TIME to File an Interim Status Report to March 27, 2020 filed by Actavis Laboratories UT, Inc. Signed by Judge Leonard P. Stark on 3/31/20. (ntl) |
| Mar 27, 2020 | 88 | Status Report (2) Docket Text: Interim STATUS REPORT by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc.. (Fahnestock, Derek) |
| Mar 20, 2020 | 87 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to File an Interim Status Report to March 27, 2020 - filed by Actavis Laboratories UT, Inc.. (Higgins, James) |
| Mar 13, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [85] STIPULATION and Order Regarding Infringement filed by LTS Lohmann Therapie-Systeme AG, UCB, Inc., UCB Pharma GmbH. Signed by Judge Leonard P. Stark on 3/12/20. (ntl) |
| Mar 13, 2020 | 86 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Opening Expert Report of Robin D. Rogers, Ph.D. on Invalidity of U.S. Patent No. 10,130,589, (2) Opening Expert Report of Dr. Mark Prausnitz, Ph.D. on Invalidity of U.S. Patent No. 10,130,589 filed by Actavis Laboratories UT, Inc..(Lee, Steven) |
| Mar 10, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [84] Stipulation and Order re expert discovery filed by Actavis Laboratories UT, Inc. Signed by Judge Leonard P. Stark on 3/10/20. (ntl) |
| Mar 9, 2020 | 85 | Stipulation (2) Docket Text: STIPULATION and Order Regarding Infringement by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc.. (Fahnestock, Derek) |
| Mar 2, 2020 | 84 | Stipulation (2) Docket Text: STIPULATION to Extend Deadlines Relating to Expert Discovery by Actavis Laboratories UT, Inc.. (Higgins, James) |
| Feb 7, 2020 | 80 | Memorandum Opinion (11) Docket Text: MEMORANDUM OPINION re claim construction. Signed by Judge Leonard P. Stark on 2/7/20. (ntl) |
| Feb 7, 2020 | 81 | Order (1) Docket Text: ORDER re [80] Memorandum Opinion regarding claim construction. Signed by Judge Leonard P. Stark on 2/7/20. (ntl) |
| Feb 7, 2020 | 82 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Supplemental Responses and Objections to Defendant Actavis Laboratories UT, Inc.'s First Set of Interrogatories (Nos. 1-3); and (2) Plaintiffs' Supplemental Responses and Objections to Defendant Actavis's Third Set of Interrogatories (Nos. 7-17) filed by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc..(Raucci, Anthony) |
| Feb 7, 2020 | 83 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Actavis Laboratories UT, Inc.'s Objections and Responses to Plaintiffs' Requests for Admission (Nos. 1-25); (2) Actavis Laboratories UT, Inc.'s Objections and Responses to Plaintiffs' Second Set of Interrogatories (Nos. 7-9): (3) Actavis Laboratories UT, Inc.'s Objections and Responses to Plaintiffs' Second Set of Requests for Production (Nos. 33-36); and (4) Actavis Laboratories UT, Inc.'s Supplemental Invalidity Contentions with Respect to U.S. Patent No. 10,130,589 filed by Actavis Laboratories UT, Inc..(Lee, Steven) |
| Feb 3, 2020 | 79 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Defendant Actavis' Third Set of Interrogatories (Nos. 7-17) filed by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc..(Fahnestock, Derek) |
| Jan 29, 2020 | 78 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Tate Edwards and Travis Messenger on February 5, 2020 and February 7, 2020 filed by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc..(Raucci, Anthony) |
| Jan 28, 2020 | 76 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Michael J. Cima on January 31, 2020 filed by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc..(Raucci, Anthony) |
| Jan 28, 2020 | 77 | Letter (2) Docket Text: Letter to The Honorable Leonard P. Stark from James L. Higgins regarding Plaintiffs' Letter and Pursuant to Court's Order - re [74] Letter, [75] Order,. (Higgins, James) |
| Jan 27, 2020 | N/A | Order (0) Docket Text: ORAL ORDER: Having received Plaintiffs' letter of January 24 (D.I. 74), IT IS HEREBY ORDERED that Defendant shall respond by letter no later than January 29. The Court anticipates issuing its claim construction order by no later than on or about February 7, 2020. ORDERED by Judge Leonard P. Stark on 1/27/20. (ntl) |
| Jan 24, 2020 | 74 | Letter (2) Docket Text: Letter to The Honorable Leonard P. Stark from Jack B. Blumenfeld regarding '589 patent claim construction for the term "A method for stabilizing". (Blumenfeld, Jack) |
| Jan 22, 2020 | 73 | Main Document (2) Docket Text: SUBPOENA Returned Executed as to Michael J. Cima on January 22, 2020 (Attachments: # (1) Exhibit 1)(Higgins, James) |
| Jan 22, 2020 | 73 | Exhibit 1 (35) |
| Jan 21, 2020 | 72 | Main Document (2) Docket Text: NOTICE to Take Deposition of Michael J. Cima on January 31, 2020, and Notice of Subpoena to Michael J. Cima filed by Actavis Laboratories UT, Inc.. (Attachments: # (1) Exhibit 1)(Higgins, James) |
| Jan 21, 2020 | 72 | Exhibit 1 (34) |
| Jan 17, 2020 | 71 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Steven W. Lee on behalf of Actavis Laboratories UT, Inc. (Lee, Steven) |
| Jan 9, 2020 | 70 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Actavis Laboratories UT, Inc.'s Revised Objections to Plaintiffs' Revised Notice of Deposition Pursuant to FRCP 30(b)(6) filed by Actavis Laboratories UT, Inc..(Higgins, James) |
| Jan 8, 2020 | 68 | Redacted Document (11) Docket Text: REDACTED VERSION of [64] Notice to Take Deposition by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc.. (Raucci, Anthony) |
| Jan 8, 2020 | 69 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Requests for Admission, (2) Plaintiffs' Second Set of Interrogatories to Defendant (Nos. 7-9), and (3) Plaintiffs' Second Set of Requests for Production of Documents and Things (Nos. 33-36) filed by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc..(Fahnestock, Derek) |
| Jan 2, 2020 | 67 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Actavis Laboratories UT, Inc.'s Third Set of Interrogatories to Plaintiffs (Nos. 7-17) filed by Actavis Laboratories UT, Inc..(Higgins, James) |
| Dec 24, 2019 | 66 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Actavis Laboratories UT, Inc.'s Objections to Plaintiffs' Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Actavis Laboratories UT, Inc..(Higgins, James) |
| Dec 20, 2019 | 65 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Brad Bath, Hahn Nghiem, Tate Edwards, Sal Rifaat and Cherri Petrie on January 8, 2020, January 9, 2020, January 10, 2020, January 14, 2020 and January 15, 2020 filed by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc..(Raucci, Anthony) |
| Dec 18, 2019 | 63 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs UCB, Inc. and UCB Pharma GmbH's Responses to Notice of Deposition to Plaintiffs Pursuant to Fed. R. Civ. P. 30(b)(6) and (2) Plaintiff LTH Lohmann Therapie-Systeme AG's Responses to Notice of Deposition to Plaintiffs Pursuant to Fed. R. Civ. P. 30(b)(6) filed by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc..(Fahnestock, Derek) |
| Dec 13, 2019 | 62 | Transcript (57) Docket Text: Official Transcript of Claim Construction Hearing held on November 25, 2019 before Chief Judge Leonard P. Stark. Court Reporter Brian Gaffigan, Email: Brian_Gaffigan@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 1/3/2020. Redacted Transcript Deadline set for 1/13/2020. Release of Transcript Restriction set for 3/12/2020.(bpg) |
| Dec 2, 2019 | 61 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Defendant's Second Set of Interrogatories (Nos. 4-6) filed by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc..(Raucci, Anthony) |
| Nov 25, 2019 | N/A | Markman Hearing (0) Docket Text: Minute Entry for proceedings held before Judge Leonard P. Stark - Markman Hearing held on 11/25/2019. (Court Reporter B. Gaffigan.) (ntl) |
| Nov 22, 2019 | 60 | Redacted Document (30) Docket Text: REDACTED VERSION of [57] Claim Construction Answering Brief by Actavis Laboratories UT, Inc.. (Higgins, James) |
| Nov 18, 2019 | N/A | Order (0) Docket Text: ORAL ORDER: Having reviewed the parties' recent letter, IT IS HEREBY ORDERED that each side will have 30 minutes for their presentation at the claim construction hearing on November 25. IT IS FURTHER ORDERED that the hearing will begin at 5:00 p.m. ORDERED by Judge Leonard P. Stark on 11/18/19. (ntl) |
| Nov 15, 2019 | 56 | Letter (1) Docket Text: Letter to The Honorable Leonard P. Stark from Derek J. Fahnestock regarding Upcoming Markman Hearing. (Fahnestock, Derek) |
| Nov 15, 2019 | 58 | Claim Construction Answering Brief (16) Docket Text: CLAIM CONSTRUCTION ANSWERING BRIEF re [45] Claim Construction Opening Brief filed by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc.. (Fahnestock, Derek) |
| Nov 12, 2019 | 55 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs UCB, Inc. and UCB Pharma GmbH's Objections and Responses to Actavis's Corrected Second Notice of Deposition to Plaintiffs Pursuant to Fed. R. Civ. P. 30(b)(6) and (2) Plaintiff LTH Lohmann Therapie-Systeme AG's Objections and Responses to Actavis's Corrected Second Notice of Deposition to Plaintiffs Pursuant to Fed. R. Civ. P. 30(b)(6) filed by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc..(Fahnestock, Derek) |
| Nov 4, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Mark C. McLennan for Actavis Laboratories UT, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Oct 31, 2019 | 54 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Actavis Laboratories UT, Inc.'s Corrected Second Notice of Deposition of Plaintiff LTS Lohmann Therapie-System AG and (2) Actavis Laboratories UT, Inc.'s Corrected Second Notice of Deposition of Plaintiff UCB, Inc. and UCB Pharma GmbH filed by Actavis Laboratories UT, Inc..(Higgins, James) |
| Oct 30, 2019 | 52 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Second Set of Interrogatories to Plaintiffs (Nos. 4-6) and this Notice filed by Actavis Laboratories UT, Inc..(Higgins, James) |
| Oct 30, 2019 | 53 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Actavis Laboratories UT, Inc.'s Second Notice of Deposition of Plaintiff LTS Lohmann Therapie-System AG, (2) Actavis Laboratories UT, Inc.'s Second Notice of Deposition of Plaintiff UCB, Inc. and UCB Pharma GmbH, and (3) this Notice filed by Actavis Laboratories UT, Inc..(Higgins, James) |
| Oct 25, 2019 | 51 | Main Document (20) Docket Text: REDACTED VERSION of [45] Claim Construction Opening Brief by Actavis Laboratories UT, Inc.. (Attachments: # (1) Exhibit 1 - 13)(Higgins, James) |
| Oct 25, 2019 | 51 | Exhibit 1 - 13 (178) |
| Oct 24, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [50] MOTION for Pro Hac Vice Appearance of Attorney Mark C. McLennan filed by Actavis Laboratories UT, Inc. Signed by Judge Leonard P. Stark on 10/24/19. (ntl) |
| Oct 22, 2019 | 49 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Leanne M. Rakers on December 11, 2019 filed by Actavis Laboratories UT, Inc..(Higgins, James) |
| Oct 22, 2019 | 50 | Main Document (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Mark C. McLennan - filed by Actavis Laboratories UT, Inc.. (Attachments: # (1) Certification by Counsel)(Higgins, James) |
| Oct 22, 2019 | 50 | Certification by Counsel (1) |
| Oct 21, 2019 | 48 | Notice (Other) (1) Docket Text: NOTICE of Withdrawal of Counsel, Micah Rappazzo by Actavis Laboratories UT, Inc. (Higgins, James) |
| Oct 18, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys James S. Trainor, Jr, Kevin X. McGann, Silvia Medina for LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Oct 18, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Catherine H. McCord for LTS Lohmann Therapie-Systeme AG, for UCB Pharma GmbH, for UCB, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Oct 18, 2019 | 46 | Claim Construction Opening Brief (21) Docket Text: CLAIM CONSTRUCTION OPENING BRIEF filed by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc.. (Fahnestock, Derek) |
| Oct 18, 2019 | 47 | Main Document (3) Docket Text: DECLARATION re [46] Claim Construction Opening Brief of Silvia Medina by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc.. (Attachments: # (1) Exhibits A-C)(Fahnestock, Derek) |
| Oct 18, 2019 | 47 | Exhibits A-C (10) |
| Oct 17, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re [43] MOTION for Pro Hac Vice Appearance of Attorney Peter C. Richardson and Traci Medford-Rosow filed by LTS Lohmann Therapie-Systeme AG, UCB, Inc., UCB Pharma GmbH. Signed by Judge Leonard P. Stark on 10/17/2019. (etg) |
| Oct 17, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re [44] MOTION for Pro Hac Vice Appearance of Attorney Catherine H. McCord filed by LTS Lohmann Therapie-Systeme AG, UCB, Inc., UCB Pharma GmbH. Signed by Judge Leonard P. Stark on 10/17/2019. (etg) |
| Oct 15, 2019 | 44 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Catherine H. McCord - filed by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc.. (Fahnestock, Derek) |
| Oct 11, 2019 | 43 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Peter C. Richardson and Traci Medford-Rosow - filed by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc.. (Fahnestock, Derek) |
| Oct 10, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [41] MOTION for Pro Hac Vice Appearance of Attorney James S. Trainor, Jr., Kevin X. McGann and Silvia Medina filed by LTS Lohmann Therapie-Systeme AG, UCB, Inc., UCB Pharma GmbH. Signed by Judge Leonard P. Stark on 10/10/2019. (etg) |
| Oct 10, 2019 | 42 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Actavis Laboratories UT, Inc.'s Objections and Responses to Plaintiffs' First Set of Interrogatories (Nos. 1-6) and Defendant Actavis Laboratories UT, Inc.'s Objections and Responses to Plaintiffs' First Set of Requests for Production of Documents and Things (Nos. 1-32) filed by Actavis Laboratories UT, Inc..(Higgins, James) |
| Oct 9, 2019 | 41 | Motion for Leave to Appear Pro Hac Vice (6) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney James S. Trainor, Jr., Kevin X. McGann and Silvia Medina - filed by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc.. (Fahnestock, Derek) |
| Oct 4, 2019 | 39 | Claim Construction Chart (9) Docket Text: CLAIM Construction Chart by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc.. (Raucci, Anthony) |
| Oct 4, 2019 | 40 | Appendix (30) Docket Text: Joint APPENDIX re [39] Claim Construction Chart by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc.. (Raucci, Anthony) |
| Sep 23, 2019 | 38 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Claim Terms for Construction filed by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc..(Fahnestock, Derek) |
| Sep 20, 2019 | 37 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Actavis Laboratories UT, Inc.'s Claim Elements and Constructions from the Asserted Claims of '589 Patent filed by Actavis Laboratories UT, Inc..(Higgins, James) |
| Sep 18, 2019 | 34 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Actavis Laboratories UT, Inc.'s Notice of Deposition of Plaintiffs UCB, Inc. and UCB Pharma GmbH, (2) Actavis Laboratories UT, Inc.'s Notice of Deposition of Plaintiff LTS Lohmann Therapie-Systeme AG filed by Actavis Laboratories UT, Inc..(Higgins, James) |
| Sep 18, 2019 | 35 | Main Document (2) Docket Text: NOTICE of Subpoenas and Deposition of Lean M. Rakers, Esquire; Harness Dickey & Pierce, P.L.C. by Actavis Laboratories UT, Inc. (Attachments: # (1) Exhibits 1 - 2)(Higgins, James) |
| Sep 18, 2019 | 35 | Exhibits 1 - 2 (72) |
| Sep 18, 2019 | 36 | Main Document (2) Docket Text: NOTICE of Subpoenas and Deposition of Lean M. Rakers, Esquire; Harness Dickey & Pierce, P.L.C. [CORRECTED] by Actavis Laboratories UT, Inc. (Attachments: # (1) Exhibits 1 - 2)(Higgins, James) |
| Sep 18, 2019 | 36 | Exhibits 1 - 2 (72) |
| Sep 13, 2019 | 33 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Defendant Actavis Laboratories UT, Inc.'s First Set of Interrogatories (Nos. 1-3) filed by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc..(Raucci, Anthony) |
| Sep 11, 2019 | 32 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Interrogatories to Defendants (Nos. 1-6) filed by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc..(Fahnestock, Derek) |
| Sep 10, 2019 | 31 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Requests for Production of Documents and Things (Nos. 1-32) filed by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc..(Fahnestock, Derek) |
| Sep 4, 2019 | 26 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Christoph Arth on October 30, 2019 filed by Actavis Laboratories UT, Inc..(Higgins, James) |
| Sep 4, 2019 | 27 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Thomas Lauterbach on November 1, 2019 filed by Actavis Laboratories UT, Inc..(Higgins, James) |
| Sep 4, 2019 | 28 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Walter Mueller on October 25, 2019 filed by Actavis Laboratories UT, Inc..(Higgins, James) |
| Sep 4, 2019 | 29 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Luc Quere on October 31, 2019 filed by Actavis Laboratories UT, Inc..(Higgins, James) |
| Sep 4, 2019 | 30 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Hans-Michael Wolff on October 29, 2019 filed by Actavis Laboratories UT, Inc..(Higgins, James) |
| Sep 3, 2019 | 25 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Actavis Laboratories UT Inc.'s Initial Invalidity Contentions with Respect to U.S. Patent No. 10,130,589 filed by Actavis Laboratories UT, Inc..(Higgins, James) |
| Aug 27, 2019 | N/A | Order (0) Docket Text: ORAL ORDER: IT IS HEREBY ORDERED that the following Scheduling Order dates are amended: Pretrial Order due by 9/18/2020. Pretrial Conference is set for 9/25/2020 at 4:00 PM. 3-day Bench Trial is set for 10/7/2020 at 8:30 AM. ORDERED by Judge Leonard P. Stark on 8/27/19. (ntl) |
| Aug 14, 2019 | 23 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant's First Set of Interrogatories to Plaintiffs (Nos. 1-3) filed by Actavis Laboratories UT, Inc..(Higgins, James) |
| Aug 13, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Micah Rapazzo for Actavis Laboratories UT, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Aug 13, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Leora Ben-Ami for Actavis Laboratories UT, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Aug 13, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Thomas F. Fleming for Actavis Laboratories UT, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Aug 13, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Christopher T. Jagoe for Actavis Laboratories UT, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Aug 12, 2019 | 22 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Defendant's First Set of Requests to Plaintiffs for the Production of Documents and Things (Nos. 1-65) filed by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc..(Fahnestock, Derek) |
| Aug 9, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [19] MOTION for Pro Hac Vice Appearance of Attorney Leora Ben-Ami, Thomas F. Fleming, Christopher T. Jagoe, & Micah Rapazzo filed by Actavis Laboratories UT, Inc. Signed by Judge Leonard P. Stark on 8/9/19. (ntl) |
| Aug 9, 2019 | 21 | Letter (1) Docket Text: Letter to The Honorable Leonard P. Stark from James L. Higgins, Esq. regarding Trial Date - re [17] Scheduling Order,,. (Higgins, James) |
| Aug 6, 2019 | 20 | Order Setting Teleconference (4) Docket Text: ORDER Setting Teleconference: plaintiffs counsel shall initiate the call. A Telephone Conference is set for 9/18/2019 at 11:30 AM before Judge Sherry R. Fallon to discuss ADR. Signed by Judge Sherry R. Fallon on 8/6/2019. (lih) |
| Aug 5, 2019 | 19 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Leora Ben-Ami, Thomas F. Fleming, Christopher T. Jagoe, & Micah Rapazzo - filed by Actavis Laboratories UT, Inc.. (Higgins, James) |
| Aug 2, 2019 | 18 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Initial Infringement Contentions for U.S. Patent No. 10,130,589 B2 filed by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc..(Raucci, Anthony) |
| Jul 30, 2019 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Magistrate Judge Sherry R. Fallon for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation (cak) |
| Jul 24, 2019 | 17 | Scheduling Order (13) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Discovery due by 2/7/2020. Status Report due by 3/20/2020. Claim Construction Opening Brief due by 10/18/2019. Claim Construction Answering Brief due by 11/15/2019. A Markman Hearing is set for 11/25/2019 at 01:00 PM in Courtroom 6B before Judge Leonard P. Stark. Proposed Pretrial Order due by 9/21/2020. A Final Pretrial Conference is set for 10/2/2020 at 09:00 AM in Courtroom 6B before Judge Leonard P. Stark. A 3-day Bench Trial is set for 10/13/2020 at 08:30 AM in Courtroom 6B before Judge Leonard P. Stark. Signed by Judge Leonard P. Stark on 7/24/19. (ntl) |
| Jul 12, 2019 | 16 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Actavis Laboratories UT, Inc.'s First Set of Requests to Plaintiffs for the Production of Documents and Things (Nos. 1-65) filed by Actavis Laboratories UT, Inc..(Higgins, James) |
| Jul 10, 2019 | 14 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Actavis Laboratories UT, Inc.'s Initial Disclosures Under Fed. R. Civ. P. 26 and D. Del. Default Standard Paragraph 3 filed by Actavis Laboratories UT, Inc..(Higgins, James) |
| Jul 10, 2019 | 15 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Initial Disclosures Pursuant to Rule 26(a)(1) and (2) Plaintiffs' Paragraph 3 Initial Disclosures filed by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc..(Raucci, Anthony) |
| Jul 8, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [12] Stipulated Protective Order filed by LTS Lohmann Therapie-Systeme AG, UCB, Inc., UCB Pharma GmbH. Signed by Judge Leonard P. Stark on 7/8/19. (ntl) |
| Jun 27, 2019 | 12 | Proposed Order (26) Docket Text: PROPOSED ORDER /Stipulated Proposed Protective Order by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc.. (Fahnestock, Derek) |
| Jun 27, 2019 | 13 | Main Document (15) Docket Text: PROPOSED ORDER /Joint [Proposed] Scheduling Order by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc.. (Attachments: # (1) Cover Letter)(Blumenfeld, Jack) |
| Jun 27, 2019 | 13 | Cover Letter (1) |
| Jun 26, 2019 | 11 | Notice (Other) (1) Docket Text: NOTICE of Withdrawal of Counsel, Michelle M. Ovanesian by Actavis Laboratories UT, Inc. (Higgins, James) |
| May 24, 2019 | 10 | Answer to Counterclaim (8) Docket Text: ANSWER to [8] Answer to Complaint, Counterclaim by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc..(Fahnestock, Derek) |
| May 3, 2019 | 8 | Answer to Complaint (18) Docket Text: ANSWER to [1] Complaint, , COUNTERCLAIM against LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc. by Actavis Laboratories UT, Inc..(Higgins, James) |
| May 3, 2019 | 9 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teva Pharmaceuticals USA, Inc., Corporate Parent Teva Pharmaceutical Industries Ltd. for Actavis Laboratories UT, Inc., Actavis Laboratories UT, Inc. filed by Actavis Laboratories UT, Inc.. (Higgins, James) |
| Mar 25, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [7] STIPULATION TO EXTEND TIME to move, answer or otherwise respond to the Complaint to May 6, 2019 filed by Actavis Laboratories UT, Inc. Signed by Judge Leonard P. Stark on 3/25/19. (ntl) |
| Mar 22, 2019 | 7 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to move, answer or otherwise respond to the Complaint to May 6, 2019 - filed by Actavis Laboratories UT, Inc.. (Sharp, Melanie) |
| Mar 13, 2019 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb) |
| Mar 7, 2019 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Actavis Laboratories UT, Inc. on 3/7/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (nmg) |
| Mar 7, 2019 | 6 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by UCB, Inc., LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH. Actavis Laboratories UT, Inc. served on 3/7/2019, answer due 3/28/2019. (Fahnestock, Derek) |
| Mar 6, 2019 | 1 | Main Document (9) Docket Text: COMPLAINT for PATENT INFRINGEMENT filed against Actavis Laboratories UT, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2587934.) - filed by UCB, Inc., LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(nmg) |
| Mar 6, 2019 | 1 | Exhibit A (16) |
| Mar 6, 2019 | 1 | Civil Cover Sheet (1) |
| Mar 6, 2019 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) |
| Mar 6, 2019 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 2/26/2019. Date of Expiration of Patent: 12/22/2030. (nmg) |
| Mar 6, 2019 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,130,589 B2. (nmg) |
| Mar 6, 2019 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent UCB S.A., Corporate Parent UCB GmbH, Corporate Parent UCB Finance N.V. for UCB Pharma GmbH; Corporate Parent UCB S.A., Corporate Parent UCB Holding Inc. for UCB, Inc.; Corporate Parent dievini Hopp BioTech Holding GmbH & Co. KG for LTS Lohmann Therapie-Systeme AG filed by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc.. (nmg) |
| Mar 6, 2019 | 1 | Complaint* (1) |
